Lataa...

MERS-CoV spike protein: Targets for vaccines and therapeutics

The disease outbreak caused by Middle East respiratory syndrome coronavirus (MERS-CoV) is still ongoing in the Middle East. Over 1700 people have been infected since it was first reported in September 2012. Despite great efforts, licensed vaccines or therapeutics against MERS-CoV remain unavailable....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antiviral Res
Päätekijät: Wang, Qihui, Wong, Gary, Lu, Guangwen, Yan, Jinghua, Gao, George F.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier B.V. 2016
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7113765/
https://ncbi.nlm.nih.gov/pubmed/27468951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2016.07.015
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!